WILMINGTON, Del. / Mar 15, 2023 / Business Wire / Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Dan Nathan, the company’s Chief Technology Officer, has been named to The Software Report’s list of the Top 25 Software CTOs of 2023.
Honorees were selected based on a proven record of high performance in leading teams to deliver solutions that streamline operations, improve efficiency and interpret data, enhancing overall business operations. This year’s list of 25 CTOs represent the driving force behind their companies’ technical capabilities, ensuring software product functionality and effectiveness.
“As technology continues to change and disrupt the way we do business, the importance of having a skilled and visionary CTO cannot be overstated,” The Software Report said in its announcement. “The CTOs being recognized on this year’s awardees list have made significant contributions to their organizations proven by a track record of success.”
In his role, Nathan oversees Phreesia’s core and integration platforms, and is responsible for the company’s Patient Intake, Data Center Operations, Site Reliability Engineering and Analytics teams. Phreesia facilitates more than 100 million patient visits annually, and Nathan’s hands-on leadership has helped propel the company’s growth and success as a leading patient intake management platform. Nathan joined Phreesia nearly 16 years ago, serving as an Architect and then Vice President of Engineering before being named CTO in 2019.
“It’s truly an honor to be recognized by The Software Report as one of the Top 25 Software CTOs,” said Nathan. “At Phreesia, we strive to help patients take a more active role in their care and improve health outcomes, and I’m proud to lead a team that is focused on driving this mission forward.”
For more information on Phreesia, visit www.phreesia.com.
About Phreesia
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency. For more information, visit Phreesia.com.
Last Trade: | US$25.16 |
Daily Change: | 1.32 5.54 |
Daily Volume: | 704,277 |
Market Cap: | US$1.460B |
December 09, 2024 October 28, 2024 October 01, 2024 September 04, 2024 July 30, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB